Razavi International Journal of Medicine

Published by: Kowsar

Evaluation of the Relationship Between Prostate-Specific Antigen and Prostate Size and Also PSA and BMI in Subjects Referred to the Check-up Clinic of Razavi Hospital

Ali Abdolhosseini 1 , * , Kambiz Totonchi Sarraf 1 , Azra Izanloo 1 and Najme Jafari 1
Authors Information
1 Department of Education and Research, Razavi Hospital, Mashhad, IR Iran
Article information
  • Razavi International Journal of Medicine: June 3, 2014, 2 (2); e15534
  • Published Online: June 3, 2014
  • Article Type: Discussion
  • Received: October 21, 2013
  • Revised: December 22, 2013
  • Accepted: March 12, 2014
  • DOI: 10.5812/rijm.15534

To Cite: Abdolhosseini A, Totonchi Sarraf K, Izanloo A, Jafari N. Evaluation of the Relationship Between Prostate-Specific Antigen and Prostate Size and Also PSA and BMI in Subjects Referred to the Check-up Clinic of Razavi Hospital, Razavi Int J Med. 2014 ; 2(2):e15534. doi: 10.5812/rijm.15534.

Copyright © 2014, Razavi Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Carter HB, partin AW. Campbell-Walsh Urology. 2002;
  • 2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1): 10-30[PubMed]
  • 3. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990; 17(4): 337-47[PubMed]
  • 4. Glovamucci EP. prostate cancer principles and practice. 2002;
  • 5. Stephan C, Xu C, Cammann H, Graefen M, Haese A, Huland H, et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol. 2007; 25(1): 95-103[DOI][PubMed]
  • 6. Olsen SH, Walzak J. Prostate cancer: rate and risk. Atlantic cancer genetics network. 2002; 68(4): 36-8
  • 7. Tulloch-Reid MK, Aiken WD, Morrison BF, Tulloch T, Mayhew R, Wan RL, et al. Body mass index and prostate specific antigen levels in Jamaican men. West Indian Med J. 2011; 60(3): 316-21[PubMed]
  • 8. Cox AK, Holliday RE, Gregory PS, Joseph WA, Fei D. The effects of body mass index on pretreatment characteristics, treatment choice, and response to treatment of intermediate- and high-grade prostate cancer. J Clin Oncol. 2012; 30(5)
  • 9. Lujan M, Paez A, Llanes L, Miravalles E, Berenguer A. Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer? Prostate Cancer Prostatic Dis. 2001; 4(3): 146-9[DOI][PubMed]
  • 10. Ayatollahi SM, Khezri AA, Shirazi M, Lotfi M, Askarian M, Ariafar A, et al. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Iran J Immunol. 2009; 6(1): 40-8[PubMed]
  • 11. Pater LE, Hart KW, Blonigen BJ, Lindsell CJ, Barrett WL. Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population. Am J Clin Oncol. 2012; 35(5): 490-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments